Quick Summary

Kokum (Garcinia indica) is a plant traditionally used to relieve inflammatory disorders. It contains bioactive compounds such as garcinol and hydroxycitric acid. Preclinical research including in vitro and animal studies suggest potential antioxidant, anti-inflammatory, antimicrobial, anti-cancer, and metabolic effects. A few human clinical trials have tested combinations including garcinol for liver-related conditions like non-alcoholic steatohepatitis (NASH). However, robust clinical evidence specific to Kokum is limited, and more rigorous human studies are needed.

What Is It?

Kokum is a tropical fruit-bearing plant native to India, scientifically known as Garcinia indica. It belongs to the Clusiaceae family and is recognized for its deep red rind and tart flavor. The fruit and extracts derived from Kokum have been used traditionally in culinary and medicinal contexts.

Traditional Uses

Traditionally, Kokum has been used to manage inflammatory conditions, support digestion, and as a cooling agent in hot climates. It has also been utilized in folk medicine for gastrointestinal issues and as a general health tonic.

Active Compounds

  • Garcinol: A polyisoprenylated benzophenone known for anti-inflammatory and epigenetic-modulating properties.
  • Hydroxycitric acid (HCA): A compound studied for its potential effects on metabolism and weight management.

Potential Benefits with Evidence Levels

  • Potential antioxidant, anti-inflammatory, and antimicrobial effects
    Evidence level: Preclinical (in vitro and animal studies)
    Study reference: Garcinol from Garcinia indica shows anti-inflammatory and antimicrobial properties in cell and animal models.
  • Potential anti-cancer properties as an epigenetic modulator
    Evidence level: Preclinical (in vitro and limited animal studies)
    Study reference: Garcinol acts as a histone acetyltransferase inhibitor affecting tumor progression pathways in preclinical studies.
  • Potential metabolic benefits including liver function improvement in non-alcoholic steatohepatitis (NASH)
    Evidence level: Human clinical trial (randomized, double-blind, placebo-controlled, combination product)
    Study reference: Combination of garcinol, curcuminoids, and piperine showed reduced liver enzymes and inflammation markers over 90 days in mild to moderate NASH patients.
  • Potential body weight and fat mass reduction
    Evidence level: Human clinical trials (meta-analyses for hydroxycitric acid from Garcinia species)
    Systematic review and meta-analysis found small statistically significant weight loss effects of Garcinia extracts/hydroxycitric acid versus placebo.
    Clinical and computational study showed hydroxycitric acid reduced body weight gain and fat accumulation in obese subjects.

Side Effects

Available clinical trial data indicate that combinations containing garcinol were generally well tolerated in short-term studies. Gastrointestinal adverse events have been reported in some studies on hydroxycitric acid extracts. Specific adverse effects related to Kokum or garcinol alone have not been well characterized in humans. Preclinical data suggest the need for further safety evaluation.

Drug Interactions

No specific data on drug interactions with Garcinia indica or its prominent compounds such as garcinol or hydroxycitric acid were identified in the current research. Due to limited clinical data, the interaction potential remains unclear. Caution is advised when combining Kokum or its extracts with prescription medications.

Who Should Avoid It

No documented contraindications were found in the available literature. However, due to the lack of comprehensive safety data, cautious use is advised especially in people with existing health conditions or comorbidities. Use during pregnancy and breastfeeding should be avoided or undertaken only under medical supervision until safety is established.

Evidence Limitations

Most evidence for Kokum derives from in vitro and animal studies with few human clinical trials. The key clinical trial involved a combination product including garcinol but not isolated Garcinia indica. Clinical evidence is limited, short-term, mostly focused on metabolic and liver outcomes with small sample sizes. Safety data are sparse and long-term effects are unknown. Robust randomized controlled trials on Kokum alone are lacking, and information on interactions, contraindications, and use in special populations remains unclear.

References

Last Reviewed

June 2024

Informational Disclaimer: This page is for educational purposes only and does not provide medical advice. Kokum and its compounds have been studied for various potential effects, but their efficacy and safety are not fully established. Always consult with a healthcare professional before starting any new supplement, especially if you are pregnant, breastfeeding, have underlying health conditions, or are taking medications.